Modulation of systemic exposure to rifaximin

Details for Australian Patent Application No. 2010260089 (hide)

Owner Salix Pharmaceuticals, Inc.

Inventors Forbes, William

Agent Pizzeys

Pub. Number AU-A-2010260089

PCT Pub. Number WO2010/148040

Priority 61/187,251 15.06.09 US; 61/297,696 22.01.10 US

Filing date 15 June 2010

Wipo publication date 23 December 2010

International Classifications

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

Event Publications

19 January 2012 PCT application entered the National Phase

  PCT publication WO2010/148040 Priority application(s): WO2010/148040

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010260097-Managing video adaptation algorithms

2010260088-Methods and compositions for long fragment read sequencing